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Abstract
Peptide Nucleic Acids (PNAs), nucleic acid analogues showing high stability to enzyme degradation and strong affinity and
specificity of binding toward DNA and RNA are widely investigated as tools to interfere in gene expression. Several studies
have been focused on PNA analogues with modifications on the backbone and bases in the attempt to overcome solubility,
uptake and aggregation issues. c PNAs, PNA derivatives having a substituent in the c position of the backbone show
interesting properties in terms of secondary structure and affinity of binding toward complementary nucleic acids. In this
paper we illustrate our results obtained on new analogues, bearing a sulphate in the c position of the backbone, developed
to be more DNA-like in terms of polarity and charge. The synthesis of monomers and oligomers is described. NMR studies
on the conformational properties of monomers and studies on the secondary structure of single strands and triplexes are
reported. Furthermore the hybrid stability and the effect of mismatches on the stability have also been investigated. Finally,
the ability of the new analogue to work as antigene, interfering with the transcription of the ErbB2 gene on a human cell
line overexpressing ErbB2 (SKBR3), assessed by FACS and qPCR, is described.
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Introduction
The search for stable and biologically active DNA mimics has
encouraged studies on Peptide Nucleic Acids (PNAs), nucleic acid
analogues showing high stability to enzyme degradation and
strong affinity and specificity of binding toward DNA and RNA.
[1,2,3,4] Several PNA analogues with modification on the
backbone and bases have been obtained so far in the attempt
to overcome solubility, uptake and aggregation issues.
[5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25]
GPNAs, PNA analogues with a guanidine group in the a position
of the backbone, designed to target the transcriptional start-site of
the E-cadherin gene, were demonstrated to effectively inhibit
protein translation, showing low toxicity and high cell permeabil-
ity. [5] These analogues were found unable to inhibit gene
transcription, probably due to electrostatic interactions with the
phosphates of nucleic acids, which slow down the diffusion of the
molecules in the cytoplasm and in the nucleus. [5] Studies on
constrained PNA oligomers showing clear conformational prefer-
ences have demonstrated that preorganization is a requisite to
increase the affinity of binding toward complementary nucleic
acids. [11,12] A recently investigated family of PNA analogues is
represented by c Peptide Nucleic Acid (c PNA), PNA derivatives
bearing a substituent, usually corresponding to the side chain of
a natural amino acid, in the gamma position of the backbone.
Several analogues have been explored so far, having methyl,
hydroxymethyl, thiomethyl, aminobutyl and guanidinium groups
attached. [13,14,15,16,17,18,19,20,21,22,23,24] CD studies on
PNA oligomers containing c hydroxymethyl have shown that these
oligomers are structurally preorganized; PNA oligomers contain-
ing (S) c Ser-PNA units show spectra typical of right handed PNA-
DNA duplexes while PNAs containing (R) c Ser-PNA form left
handed helices. [19] The secondary structure of the oligomers
depends on the position of the chiral moiety and is induced when
the chiral moiety is at the C-terminus. Recently the crystal
structure of a c PNA/DNA duplex has been solved; these studies
revealed that the helix is induced by the steric clash between the c
carbon and the nitrogen of the tertiary amide of the backbone and
is stabilized by the sequential base stacking. [26] The incorpora-
tion of one S chiral unit in a PNA oligomer enhances the stability
of the duplex hybrids, yielding an increase of 3uC in the melting
temperature of PNA/DNA duplexes and of 2uC for PNA/RNA
hybrids; [19] oligomers containing monomers with R chirality,
instead, bind DNA and RNA with low affinity and selectivity.
Interestingly the stability of the hybrids is not influenced by the
spacing between the chiral units. Furthermore c PNA is the only
analogue discovered so far having the ability to invade a mixed
sequence DNA double helix. [27].
Encouraged by these results and with the aim to develop a new
PNA analogue more DNA-like in terms of polarity, charge and
solubility we undertook studies on c PNAs having a sulphate
moiety in the c position of the backbone. The sulphate group is, in
fact, very similar to the phosphate of DNA, in geometry, steric
hindrance, polarity; furthermore a sulphate monoester has the
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The sulphate PNAs should in principle keep the advantages of
standard PNAs (stability to degradation and binding affinity) and
in addition should be more soluble, less prone to aggregation. Two
more advantages of this negatively charged analogue should be: 1)
the lack of unspecific interactions with nucleic acids, which instead
may occur with positively charged PNA analogues, as observed in
a guanidine PNA; 2) the possibility to increase its uptake
employing the tools commonly used for DNA transfection. In fact
PNA and PNA analogues (with the only exception of c guanidine
PNA), [23] although showing high binding affinity towards natural
nucleic acids and high stability to enzymatic degradation, do not
easily cross the cell membrane and consequently show weak
biological activity. In this respect, it is worth noting that many
studies have been carried out with the aim to improve the uptake
of PNA; the delivery of PNA by lipofectamine or other cationic
lipids employed for the common DNA delivery has been
demonstrated only for PNA complexed to DNA or PNA
conjugated to negatively charged peptides. [28,29,30,31,32,33]
To evaluate the antigene activity of sulphate PNA, the ErbB2 gene
was chosen as target. ErbB2 is a known proto-oncogene over-
expressed in numerous cancers, including breast and ovarian
tumors and is correlated to increased chemoresistance of the
cancer cells. [34] ErbB2 encodes a protein member of the EGFR/
ErbB protein family and is a cell membrane surface-bound
receptor tyrosine kinase, which is normally involved in the signal
transduction pathways leading to cell growth and differentiation.
[35] EGFR signaling is activated by unspecific ligand binding to
the extracellular domain of the receptor. This determines receptor
homo2/hetero-dimerization and a subsequent autophosphoryla-
tion by the intracellular kinase domain, resulting in receptor
activation. After activation, phosphorylation of cytoplasmic
substrates occurs and a signaling cascade drives many cellular
responses, which include changes in gene expression, cytoskeleton
rearrangement, anti-apoptosis and increased cell proliferation.
[36].
In this work we investigated c sulphate PNAs. We set up
protocols for the synthesis of the four PNA monomers having the
sulphate group in the c position of the backbone and of oligomers
containing sulphate monomers. The conformational preferences of
the PNA monomers were investigated by NMR. Studies on the
secondary structure of a polypirimidine oligomer were carried out
by CD. The ability of the modified oligomer to interact with DNA,
the specificity and affinity of binding were investigated by UV and
CD. Finally, we explored the ability of the sulphate PNA to
interfere with the transcription of the ErbB2 gene by targeting its
promoter on a human cell line overexpressing ErbB2 (SKBR3).
The sequence chosen as target is localized from 2220 to 2228
upstream of the first codon. [37] Analysis performed by FACS,
fluorescence microscopy and qPCR, demonstrated that PNA S
inhibits gene expression of HER-2 and reduces ErbB2 receptor
number on cell surface.
Results
Synthesis of the PNA Monomers and Oligomers
The PNA c sulphate monomers are obtained after derivatiza-
tion of c hydroxymethyl monomers (Figure 1,), synthesized using
a modified version of the protocol reported in the literature for c
hydroxymethyl PNA starting from L-Fmoc-Ser(OtBu)-OH. [19]
(Supporting S1).
In the monomers the exocyclic amines of the nucleobases A, C
and G are protected with base labile groups, benzoyl for A and C,
isobutyryl for G. [38,39,40] The sulphate was installed on the
hydroxyl after reaction with the DMFNSO3 complex and treatment
with tetrabutylammonium (TBA) hydrogen sulfate/NaHCO3.
The treatment of the sulphate monomers with tetrabutylammo-
nium is needed in order to stabilize the acid labile sulphate group.
[41] The stability of the sulphate to both acidic and basic
conditions was verified in two separate experiments, carried out
treating the t
S monomer with the cleavage and deprotection
solutions, respectively a concentrated TFA solution for 2 hours at
room temperature and a concentrated ammonia solution at 50uC
for 16 hours (data not shown). The reactions were monitored by
LC-MS; except for the removal of the Fmoc group occurring in
basic conditions, no other reaction was observed, demonstrating
thus that the TBA counterion is sufficient to stabilize the sulphate
group. All monomers were characterized by electrospray mass
analysis and NMR.
The coupling conditions on solid phase for all the monomers
were set up testing different mixtures of activators and bases. The
best coupling conditions are found to be the following. For Fmoc-
t
S-OH: 50 mL of a 0.3 M solution (7.9 eq.) in an. DMF of
monomer, 50 mL of HBTU (0.2 M) (5.2 eq.) in DMF, 50 mL
MDCH (0.8 M) in pyridine, 30 minutes. For Fmoc- c
S (Bz)-OH,
Fmoc-a
S (Bz)-OH, Fmoc g
S (iBu)-OH: 50 mL of a 0.3 M solution
(7.9 eq.) in an. DMF of monomer, 50 mL of HBTU (0.2 M)
(5.2 eq.) in DMF, NMM 0.2 M, 50 mL of pyridine 0.2 M in DMF,
30 minutes.
The sequence chosen to target the ErbB2 gene promoter,
CTCCTCCTC, encompasses the tract from 2220 to 2228
upstream of the first codon. [37] In the sequence all T were
inserted as sulphate T (t
S).
The oligomer ct
Scct
Scct
Sc (PNA S) was assembled on a PAL-
PEG resin using standard conditions for the standard monomers
and the conditions described earlier for the t
S building blocks. The
oligomer was cleaved in standard conditions, purified by RP-
HPLC and characterized by LC-MS. (Supporting S2 and Figure
S1).
The unmodified PNA ctcctcctc (PNA) was obtained using
standard protocols, [42] purified by RP-HPLC, characterized by
electrospray and used in the control experiments. (Supporting S2).
The FITC conjugated PNA S and PNA were obtained coupling
at the N-terminus of PNA S or PNA first the amino-hexanoic acid
linker and then the FITC. (Supporting S3, Figure S2 and Figure
S3).
The oligomer containing hydroxymethyl modified c PNA T
monomer (t
OH), c t
OHcct
OHcct
OHc (PNA OH) was obtained as the
ct
Scct
Scct
Sc and the t
OH monomer was coupled as the t
S
monomer. (Supporting S2).
NMR Studies
We performed NMR experiments on Fmoc-PNA
OH and
Fmoc- PNA
S monomers dissolved in DMSO.
We will describe results obtained for the guanine monomer, but
the same spectral features were also observed for the other
monomers.
An expansion of the backbone region of the 2D-TOCSY for the
two guanine monomers (g
OH in red and g
S-OH in blue) is reported
in Figure 2.
Because of the well-known restricted rotation around the
tertiary amide bond in PNA that produces two possible rotamers
in solution around the C7–N4 bond (tertiary amide bond), the spin
systems in the NMR spectrum are duplicated. As expected, the
introduction of the sulphate group in the c position of the
backbone results in a discernible shift of the signals toward lower
fields (Table 1).
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geometry of the tertiary amide bond: a NOE cross-correlation
peak between H-8 and H-3 is found in the conformation where the
carbonyl C-7 points toward the C terminus (rotamer A), and
a NOE cross-correlation peak between H-8 and H-5 where the C-
7 carbonyl group points toward the N terminus (rotamer B)
(Figure 3). A clear difference is evident between the two
monomers: the signals for rotamer A and B of the Fmoc-g
OH-
OH monomer have a comparable intensity while in the Fmoc-g
S-
OH monomer the signals of rotamer A have about two times the
intensity of those of rotamer B. The conformational preferences of
the Fmoc-g
S-OH monomer have been deduced by identifying and
evaluating the coupling pattern of the spin system composed of H-
2, H-3a, H-3b in the DQ-COSY experiment. The signal of H-3a
for rotamer A appears as a doublet of doublets with coupling
constants of ,15 and ,10 Hz, while H-3b appears as a doublet of
doublets with coupling constants of ,15 and ,5 Hz. This suggests
the presence of a preferred conformation in solution that involves
one trans diaxial interaction (180u) between H-2 and H-3a (J of
,10 Hz) and an axial to equatorial interaction (+60u) between H-
2 and H-3b (J of ,5 Hz). The ,15 Hz coupling constant
corresponds to the geminal coupling (J2) between H-3a and H-3b.
For rotamer B we observe: the ,10 Hz coupling constant
corresponding to a trans diaxial relationship measured between
H-3b and H-2, and a ,5 Hz coupling constant corresponding to
an equatorial to axial relationship between H-3a and H-2. With R
being the absolute configuration at C-2, the conformation that
produces the relative spatial arrangement of protons H-2, H-3a,
and H-3b in rotamer A corresponds to that observed in PNA
monomers when they are in oligomers forming a right-handed
helix. The conformation of rotamer B corresponds to an extended
conformation. (Figure 4).
Determination of the Stoichiometry of the Complexes by
the Continuous Variation Method
Polypirimidine PNA sequences are known to hybridize DNA
forming triplexes of stoichiometry PNA2/DNA. In order to
determine the stoichiometry of the polypirimidine PNA S/DNA
complex, we employed the continuous variation method. The
absorbance at 260 nm of PNA S (and PNA) and DNA solutions at
different PNA S (PNA)/DNA ratios was measured. The plots of
the absorbance vs the molar fraction of the PNA S (PNA) show in
both cases a minimum around 0.7 of molar fraction, which
suggests a stoichiometry 2:1 PNA S (PNA):DNA. The presence of
sulphates in the side chain of the oligomer PNA S does not hamper
the formation of hybrids with complementary DNA; the
stoichiometry of the hybrid suggests that PNA S follows the same
hybridization rules as standard PNA.
CD Studies
CD spectra of the oligomer ct
Scct
Scct
Sc (PNA S) were recorded
at different concentrations. A very weak signal appears when the
oligomer has a 10 mM concentration; the CD spectrum shows
a deep minimum at 267 nm and a very shallow minimum at
238 nm. The CD spectrum of PNA S was compared to that of
PNA OH, the analogue oligomer containing t
OH monomers
(Table 2 and Figure 5): the spectrum of PNA OH shows more
Figure 1. PNA monomers. Schematic representation of standard and modified PNA monomers.
doi:10.1371/journal.pone.0035774.g001
Figure 2. NMR characterization of the monomers. Superimposi-
tion of the 2D-TOCSY, expansion of the backbone region, for the g
S and
g
OH monomers.
doi:10.1371/journal.pone.0035774.g002
Table 1.
1H chemical shift (ppm) for the g
S and g
OH backbone
protons. See Figure 3 for numbering.
g
S rotamer A g
S rotamer B g
OH rotamer A g
OH rotamer B
1 7.53 7.32 7.43 7.12
2 4.04 3.85 3.90 3.67
3a 3.69 3.47 3.49 3.33
3b 3.39 3.21 3.37 3.16
9 3.87 3.71 3.67 3.57
doi:10.1371/journal.pone.0035774.t001
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triplexes formed by PNA S with complementary DNA was also
investigated by CD and compared to the structure of a triplex
formed by the unmodified PNA oligomer. CD spectra for the two
hybrids are superimposable, showing two maxima at 270 and
225 nm and one minimum at 250 nm (Figure 6). The spectrum
recorded for the DNA triplex, as expected, is different. PNA S
forms a triple helix having the features of the P-helix formed by
standard PNA. [43]
The stability of the hybrid was investigated by melting
experiments followed by CD. Melting curves were recorded for
the (PNA S)2DNAc and, as a control, for the (PNA)2DNAc and for
the (DNA)2DNAc triplexes (see Table 2 for the sequences of the
oligomers).
In all cases a single transition was observed. The Tms were
estimated to be 52.2uC for (PNA)2DNAc, 46.6uC for (PNA
S)2DNAc and 42.2uC for (DNA)2DNAc (Table 3). The effect of
the introduction of one mismatch in the complementary DNA
strand on the melting temperature of the hybrids was investigated
in two cases: when the mismatched base is complementary to
a PNA monomer in PNA S (DNA mis: GAGCAGGAG) and when
the mismatched base is complementary to a t
S monomer (DNAc
mis S: GAGGTGGAG). A significant decrease in the melting
temperature of the triplex was observed in both cases, being larger
(222.4uC) for the latter, demonstrating thus the high selectivity in
the binding of sulphate modified PNAs. In parallel the same effect
was investigated on hybrids formed by PNA and DNA oligomers
by measuring their melting temperature. The triplexes
(DNA)2DNA mis S and (PNA)2DNA mis S have a melting
temperature respectively 15.4uC and 19.7uC lower than the
perfectly matched hybrid. Furthermore, as the thermal stability of
DNA hybrids depends on the ionic strength, unlike that of hybrids
formed by standard PNA, [44] being increased at high ionic
strength, we investigated the effect of the ionic strength on the
Figure 3. Monomers rotamers. Representation of the two rotamers found for the sulphate monomer g
S.
doi:10.1371/journal.pone.0035774.g003
Figure 4. Sulphate monomers conformation. The two hypothesized conformations for the g
S monomers.
doi:10.1371/journal.pone.0035774.g004
Table 2. Oligomers sequences. PNA bases are indicated with
lower case letters, DNA bases with upper case letters.
Name sequence number
PNA S ct
Scct
Scct
Sc1
PNA ctcctcctc 2
PNA OH ct
OHcct
OHcct
OHc3
DNA CTCCTCCTC 4
DNAc GAGGAGGAG 5
DNA c mis GAGCAGGAG 6
DNA c mis S GAGGTGGAG 7
doi:10.1371/journal.pone.0035774.t002
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S)2 DNA was found dependent on the ionic strength, being
increased by about 4uC when the concentrations of NaCl and
MgCl2 are doubled (Table 3).
Cytotoxicity Assay
We performed a cytotoxicity assay on SKBR3 cells with
increasing concentrations of PNA S. Results showed no significant
difference on cell survival with respect to SKBR3 grown in the
absence of the oligonucleotide analogues (data not shown). Thus,
these data demonstrate that there is no intrinsic toxicity of the
sulphate PNA on our cellular model.
Cellular Uptake of FITC-oligomers
To evaluate the cellular uptake of PNA S and PNA in the
presence of lipofectamine, SKBR3 cells were treated with FITC
labelled molecules and analysed by flow cytometry and
fluorescence microscopy. Fluorescence of cells treated with
FITC-PNA S is markedly higher with respect to that of cells
that incorporated PNA, on equal conditions as demonstrated
and quantified by FACS analyses (Figure 7, Panel A) and
confirmed by fluorescence microscopy experiments (Figure 7,
panel B). These results clearly demonstrate the more efficient
uptake of the PNA S in SKBR3 cells with respect to PNA
mediated by lipofectamine.
qPCR
A quantitative analysis of ErbB2 expression was obtained by
qPCR. In detail, SKBR3 cells were transfected for 48 h with
different amounts of PNA S or PNA in the presence of
lipofectamine and then total RNA was extracted from cells.
Following the reverse transcription, performed using random
primers and MMLV reverse-transcriptase, a qPCR reaction was
carried out using specific primers for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, a housekeeping gene, used as reference
gene) and ErbB2. Data from this analysis showed that the PNA S
was able to reproducibly down-regulate ErbB2 expression at all
concentrations tested. The expression of ErbB2 in the presence of
10 mM PNA S was significantly lower than that at 5 mM. In
contrast, treatment with PNA does not reduce ErbB2 gene
expression (Figure 8).
Flow Cytometric Analysis
The ability of PNA S to recognize a specific DNA sequence was
determined by analyzing its effect on the reduction of the amount
of ErbB2 receptor on cell surface of SKBR3 cells overexpressing
ErbB2 by flow cytometric assays. In particular, SKBR3 cells were
transfected with PNA S in the presence of lipofectamine at
different concentrations of the compound. The cells, harvested
after 48 h, were incubated in the presence of Herceptin as primary
antibody. The signal, indicating the binding of Herceptin to the
receptor on SKBR3 cell surface, significantly decreases in the
presence of increasing amount of PNA S. In contrast, there was no
signal change when cells were transfected with PNA in the same
conditions. This experiment suggests that the PNA S, unlike PNA,
is able to inhibit the expression of the receptor in a dose-response
manner (Figure 9).
Discussion
In this paper a new PNA analogue is investigated: for the first
time a sulphate group has been attached to the PNA backbone
and the effects of the modification on the monomers conforma-
tion and oligomer hybridization properties have been analyzed.
The position c of the backbone was chosen based on data
reported in the literature showing that the presence of
substituents in the c position does not hamper formation of
duplex and triplex hybrids, and contributes to the oligomer
structural organization. We employed NMR tools to determine
the conformation of the monomers. Two rotamers were
identified for each monomer, as reported for other c modified
PNAs. Analysis of the NOESY spectra recorded for the sulphate
monomers and comparison with the spectra of hydroxymethyl
modified monomers reveals a clear difference in the population
Figure 5. CD of single strands. CD spectra of PNA S (–) and PNA OH
(–) in 10 mM Phosphate buffer 100 mM NaCl, 5 mM MgCl2,p H7a t
10 mM strand concentration.
doi:10.1371/journal.pone.0035774.g005
Figure 6. CD of triplexes. CD spectra of (PNA S)2DNAc (–),
(PNA)2DNAc (–) in 10 mM Na Phosphate buffer, 100 mM NaCl, 5 mM
MgCl2, pH 7 at 3 mM triplex concentration.
doi:10.1371/journal.pone.0035774.g006
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unlike the hydroxymethyl precursors, prefer the conformation in
which the C-7 carbonyl group points toward the C-terminus.
DQ-COSY experiments on the sulphate monomers, revealed
that the two different rotamers existing for each monomer show
two different conformations, respectively the right handed helix
and the extended conformation. These data suggest that the
introduction of a sulphate in the c position of the backbone
partially modifies the conformational preferences of c modified
hindered monomers. Interestingly, the conformation of rotamer
A reproduces the situation observed in valine and isoleucine c
modified monomers. [26] The restricted rotation around C2–C3
forces the monomer in a specific conformation, corresponding to
the one adopted in a right handed helix. On the other hand,
rotamer B, assumes a more extended conformation, as
demonstrated by the inversion in the pattern of coupling
constants. Thus the sulphate side chain reproduces an in-
termediate situation between that observed in very hindered
monomers as valine and isoleucine PNAs and in monomers with
less hindered side chains as alanine and hydroxymethyl. The
effect of the sulphate side chain on the secondary structure of the
modified oligomer was investigated by CD, comparing the
spectra for PNA S and PNA OH. It is reported in the literature
that PNA oligomers containing c hydroxymethyl monomers
adopt the structure of a right handed helix. [19] The spectra
recorded for PNA S and PNA OH show bands in the same
position, with the bands in PNA S spectrum being far less intense
(Figure 5). This result suggests that the PNA S oligomer has
a lower content of secondary structure as compared to the PNA
OH oligomer. This likely reflects the presence of a population of
monomers which assumes an extended conformation, as assessed
by NMR, and does not induce any secondary structure in the
oligomer. Furthermore it is also reasonable to hypothesize that
the electrostatic repulsions between the negative charges and the
steric hindrance of sulphates in the backbone contribute to the
helix unwinding in PNA S. The lack of a defined secondary
structure in the single stranded PNA S does not affect its ability
to form hybrids with complementary DNA. Analysis of the
stoichiometry of the complexes by the continuous variation
method reveals that the homopyrimidine PNA S forms triplexes
with DNA, following the standard hybridization scheme (PNA
2:DNA). The CD signature of the PNA S triplex is superimpos-
able upon that of a standard PNA triplex, suggesting that PNA S
triplex assumes the secondary structure of a P-helix. Interestingly
the PNA S triplex is thermally more stable than the DNA triplex.
However a destabilization with respect to the standard PNA
hybrid is observed, which can be explained considering the
electrostatic repulsion between the negatively charged phosphate
of DNA and sulphate of PNA S. The remarkable decrease in the
melting temperature of PNA S hybrids containing a single
mismatch in correspondence of the sulphate monomer indicates
that it has the highest selectivity in the binding of DNA as
compared to PNA and DNA. The hybridization properties
displayed by PNA S urged us to explore its biological activity.
PNA S is complementary to a tract of the ErbB2 gene promoter
and, therefore, its ability to work as an antigene may be
investigated. To this end qPCR and FACS experiments were
carried out to determine the amounts respectively of the ErbB2
gene expressed and the ErbB2 protein produced on the surface
of SKBR3 cells.
qPCR and FACS analyses demonstrate that a treatment of
SKBR3 cells with PNA S determines a significant decrease both in
gene expression and in the amount of receptor on SKBR3 cell
Table 3. Melting temperature of the triplexes dissolved in 10 mM Na Phosphate buffer, 100 mM NaCl, 5 mM MgCl2, pH 7; * higher
ionic strength: 10 mM Na Phosphate buffer, 200 mM NaCl, 10 mM MgCl2,p H7 .
triplex (1)25 (1)26 (1)27 (2)25 (2)27 (4)25 (4)27 (1)25*
Tm 46.6 29.6 24.2 52.2 32.5 42.2 26.8 50.8
doi:10.1371/journal.pone.0035774.t003
Figure 7. Uptake analysis of FITC-oligomers in SKBR3 cells. Cells are treated with 1 mM FITC-PNA S or FITC-PNA in the presence of
lipofectamine and analysed by flow cytometric assay (A) and immunofluorescence analysis (B). In panel A, black curve represent not transfected cells,
blue curve cells transfected with FITC-PNA, red curve cells treated with FITC-PNA S.
doi:10.1371/journal.pone.0035774.g007
Peptide Nucleic Acid analogues
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promoter, likely forming a triplex, and acts as an antigene.
Fluorescence experiments carried out on fluorescein labeled
PNA and PNA S complexed to lipofectamine on SKB3 cells,
reveal that cells intake PNA S to a great extent, whereas the PNA
uptake seems to be poor.
Interestingly PNA S forms triplexes less stable than the standard
PNA, but it exhibits a biological activity unlike PNA. One of the
major challenges in the design of an antigene molecule is the
optimization of its DNA affinity binding, which is achieved in
several ways, for example conjugating to the PNA intercalating,
chelating and alkylating agents, or using bis PNA.
[37,45,46,47,48,49,50,51] The results of the experiments carried
out with PNA S highlight the importance of the specificity in the
DNA binding, other than the affinity. Finally, in this case it can be
hypothesized that the differences between PNA and PNA S are
due to the different uptake of the molecules as well: the negatively
charged PNA S reasonably binds strongly the cationic lipids used
for the delivery, being able to reach the nucleus in a sufficient
amount to determine the antigene effect, unlike PNA which,
lacking of charge, is not efficiently delivered to the nucleus and
therefore does not display any biological activity. Our hypothesis is
consistent with data recently published in the literature [9] and is
supported by the results of fluorescence experiments; other assays,
as for example the Chromatin Association Assay might be carried
out to demonstrate that PNA S bind to DNA in vivo. [52] Data
obtained so far underline how critical is the efficiency in the uptake
to determine the biological activity of PNA analogues. In
conclusion PNA S is the first example reported so far of antigene
c PNA bearing a negative charge. The introduction of the sulphate
group in the c position of the backbone positively influences the
binding properties and the biological activity of the oligomer. PNA
S shows a strong binding selectivity toward DNA and a potent
antigene activity. The lack of toxicity encourage us to further
investigate the application of PNA S in strategies aimed at
interfering in gene expression, increasing the length and
consequently the specificity of PNA oligomers in order to target
unique sites in DNA/RNA binding sites.
Methods
Synthesis of the Monomers
Sulphate monomers were obtained after derivatization of the c
hydroxymethyl monomer, synthesized following procedures de-
scribed in the literature. [19] The protocol to install the sulphate is
here described for the a
S monomer, but applies to all other
monomers as well.
Figure 8. qPCR of ErbB2 and GAPDH genes. RNA was obtained
after transfection of SKBR3 cells with PNA S or PNA at 5 and 10 mM
concentration. The experiments were performed in triplicate and
repeated at least 3 times. Data indicate the relative gene expression
of cells treated with PNA S or PNA versus not treated cells, error bars
represent the standard deviation of the mean. Statistical significance
was carried out by means of the two tailed paired Student’s t test,
*p=0.02; **p=0.0006.
doi:10.1371/journal.pone.0035774.g008
Figure 9. Flow cytometric analysis of ErbB2 expression on SKBR3 cells. Cells are treated with different amounts of PNA S and PNA in the
presence of lipofectamine. (A) Single result representative of three similar experiments. Not transfected cells (black curve), not transfected and
treated cells with an antiErbB2 antibody (green curve), transfected with 10 mM PNA S and treated with an antiErbB2 antibody (red curve) and
transfected with 10 mM PNA and treated with an antiErbB2 antibody (blue curve). (B) Histograms were obtained from at least three independent
experiments. Data are expressed as percentage of decrease versus control (cells not transfected and treated with an antiErbB2 antibody) 6 SE.
Statistical significance was carried out by means of the two tailed paired Student’s t test, **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0035774.g009
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OH-OH) (143 mg,
0.22 mmol) is dissolved in 1.2 mL of DMF and stirred under
argon 10 minutes. DMF?SO3 (134.8 mg, 0.88 mmol) is added and
the reaction is carried out for 2 hours under argon at r.t. The
solvent is evaporated. Separately a solution of NaHCO3
sat.(2.86 mL) and tetrabutylammonium bisulfate (154.4 mg) is
prepared and cooled at 0uC; this solution is added to the reaction
mixture and reacted under stirring for 5 minutes. The pH of the
solution is then adjusted to 5 with a 10% solution of citric acid.
The crude is extracted 4 times with CHCl3 and the organic layer is
dried under vacuum. Yield: 95%.
NMR Spectroscopy
The 2D spectra were acquired using the TPPI (time-pro-
portional phase-incrementation) method to obtain complex data
points in the t1 dimension. A standard set of 2D experiments
DQF-COSY, TOCSY and NOESY were acquired at 25uC.
[53,54,55] The TOCSY experiments were recorded using
a MLEV17 mixing scheme of 70 ms with 9 kHz spin-lock field
strength; the NOESY spectra were carried out with a mixing time
of 150 ms. Chemical shifts were referenced to external TMS
(tetramethylsylane) (d=0 ppm). For data processing and spectral
analysis the programs VNMR 6.1B and CARA were used. [56] All
samples were purified by HPLC before analysis.
Determination of the Stoichiometry of the Complex by
Job Plot
Concentration of the single strands was determined by UV at
260 nm, using for PNA S and PNA e=64.5 Lmol
21cm
21 and for
DNA e=101.6 Lmol
21cm
21.3mM solutions of PNA S, PNA and
DNAc in phosphate buffer 10 mM, 100 mM NaCl, pH=7 were
prepared. Solutions at different molar fraction of PNA S (or PNA)
and DNAc were prepared, keeping constant the (PNA S or PNA +
DNA) total concentrations. Samples were annealed, warming to
90uC and slowly cooling to 4uC. UV spectra were recorded on
a Jasco spectrophotometer at 25uC.
CD Analyses
CD spectra were recorded at 5uC in the 320–200 nm range and
are the results of 6 scans. Single strands and triplexes were
dissolved in phosphate buffer 10 mM, 100 mM NaCl, 5 mM
MgCl2 pH=7. Triplexes were annealed by warming up at 90uC
and slowly cooling to 4uC.
Thermic denaturation experiments were carried out using
3 mM triplexes at a 0.5uC/min scan speed, recording at 225 nm
for PNA S and PNA and at 266 nm for DNA triplexes.
Cell Culture
SKBR3 cells (ATCC, U.S.) were grown in DMEM supple-
mented with 10% fetal bovin serum (FBS), 1% glutamine, 100 U/
mL penicillin and 100 mg/mL streptomycin (Invitrogen, U.S.), at
37uC and 5% CO2.
Citotoxicity Assay
For the evaluation of the cytotoxic effect of compounds, the
exponentially growing cells were seeded at a density of 5.0610
3/
well in 96-well flat bottom tissue culture microplates, and
incubated with 1, 5 and 10 mM of PNA S at 37uC for 72 hours.
Cell number was evaluated with crystal violet, which correlates
optical density with cell number, according to the procedure
described by Gilles et al. [57].
Cellular Uptake by FACS and Fluorescence Microscopy
7.5610
4 cells/well were plated in 24-well plates with or without
cover glasses, allowed to adhere for 24 hours, and then transfected
using Lipofectamine LTX (Invitrogen, CA, U.S.) according to the
manufacturer’s instructions, with FITC-PNA S or FITC-PNA.
After 24 hours, cells were detached, then washed with PBS 1X,
0.1% BSA and analyzed by flow cytometer, equipped with
a 488 nm argon laser (FACScalibur Becton Dickinson, U.S.). For
each sample 10.000 events were acquired and analyzed using Cell
Quest software. At the same time, cover glass adherent cells were
fixed with 4% formaldehyde and analyzed by Axiovert 200 Zeiss
microscopy fluorescence.
RT-PCR and qPCR
Total RNA was extracted from lysates of transfected cells by
using Tri-reagent
TM (Sigma Aldrich, U.S.) according to the
manufacturer’s instructions. Reverse transcription was performed
using 0.5 mg of total RNA, 200 U of MMLV (Finnzymes, Finland)
and 250 ng of random primers (Fermentas, Germany). Reaction
temperature was set at 42uC for 1 hour. The reaction buffer was:
50 mM Tris HCl pH 8.3; 75 mM KCl; 3 mM MgCl2;5m M
DTT. After reverse transcription, qPCR assay was carried out
using the following primers, GAPDH: forward primer, 59-
ATGGGGAAGGTGAAGGTC-39, reverse primer 59-GTCATG-
GATGACCTTGGC-39; ErbB2: forward primer, 59-GGGAA-
GAATGGGGTCGTCAAA-39, reverse primer 59-
CTCCTCCCTGGGGTGTCAAGT-39 (purchased from Sigma-
Genosys Ltd). The amplification reactions were run at least in
triplicate. The reactions contained 50 ng of cDNA, 3 ml of primers
(10 mM each), and 10 ml of SYBR Premix Ex Taq II (Takara,
Japan), in a final volume of 25 ml. The qPCR protocol was as
follows: 2 minutes at 95uC followed by 45 cycles of 1 minute at
95uC, 1 minute at 60uC and 1 minute at 72uC and the experiment
was performed in Rotor-gene Q (Qiagen).
SKBR3 binding assay by fluorescence activated cell
sorting (FACS). 7.5610
4 cells/well were plated in 24-well
plates, allowed to adhere for 24 hours, and then transfected using
Lipofectamine LTX with PNA S or PNA. After 48 hours, cells
were incubated with 10 nM Herceptin (kindly provided by Dr. S.
De Luca, IBB, CNR Italy), then washed with PBS 1X, 0.1% BSA
and incubated with a 1:1000 dilution of primary antibody (mouse
anti-human, clone HP6017, SIGMA, U.S.). Secondary antibody
(goat anti-mouse FITC-conjugate, Santa Cruz, CA, U.S.) was used
at 1:200 dilution. Subsequently cells were detached, resuspended
in PBS 1X, 0.1% BSA and analyzed by flow cytometer. For each
sample 20.000 events were acquired and analyzed using Cell
Quest software.
Supporting Information
Figure S1 HPLC profile for the pure PNA S.
(TIF)
Figure S2 HPLC, mass spec and UV profile of FITC-
PNA.
(TIF)
Figure S3 HPLC and UV profile of FITC-PNA S.
(TIF)
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